Skip to content

Clinical trials

Recruiting Phase 2 Carcinoma, Intraductal, Noninfiltrating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Intraductal, Noninfiltrating Phase: Phase 2 Status: Recruiting Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20211
20221
20232
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Fudan University1
Institut Cancerologie de l'Ouest1
Memorial Sloan Kettering Cancer Center1
QuantumLeap Healthcare Collaborative1
UNC Lineberger Comprehensive Cancer Center1
University of Utah1
University of Wisconsin, Madison1
Universität Münster1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Intraductal, Noninfiltrating13
Breast Neoplasms11
Breast Carcinoma In Situ3
Carcinoma, Ductal, Breast1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.